Skip to Main Content

A consumer advocacy group is asking regulators to “immediately remove” a widely used gout medication over concerns that it poses “unique, serious,” and potentially “fatal” risks to patients while not offering any health benefit.

In a petition sent to the Food and Drug Administration on Thursday, Public Citizen argued there is “overwhelming evidence that the serious cardiovascular harms of (Uloric) outweigh any purported clinical benefit,” and that a failure to remove the drug ensures “further preventable harm” to patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!